FDA: Contrave diet pill data lacks cardio insight; 10k sample search seeks diabetes tipoff;

> Orexigen meets with an FDA panel Tuesday about the diet pill Contrave and its lack of data to evaluate long-term cardiovascular risks. Trials were too short and small and included too few participants had a history of heart disease, according to agency documents posted ahead of the meeting. Article

> In an effort to predict T1 diabetes susceptibility, Oxford Gene Technology will work with the University of Virginia to canvass 10,000 patient samples for genomic variations. Story

> Recruitment software specialist DecisionView has launched version 4.2 of the StudyOptimizer solution for patient enrollment planning, tracking and forecasting. DecisionView release

> Transgenomic is buying Clinical Data's diagnostics business. News

> Cosmo Pharmaceuticals reports positive results from a Phase III clinical study, for which it used DATATRAK's unified eClinical product suite and services, evaluating ulcerative colitis treatment budesonide MMX. Cosmo release

> Virtify is preparing to release Virtify for Submissions, a structured content management software platform for regulatory submission documents. Virtify announcement

> InnovoCommerce announces version 3.1 of the SharePoint-based innovoPOINT clinical and investigator portal for secure document exchange and clinical trial business process automation. InnovoCommerce release

> Clinical data management consultancy Eliassen Group has acquired the IT staffing division of Dextrys, a provider of product engineering and application services outsourcing. Eliassen release

> Southampton University School of Medicine is using radio chromatography systems from LabLogic in the development of radio-labeled antibody conjugates for treating hematological malignancies. LabLogic announcement 

> CTMS supplier BioClinica welcomes oncology-focused CRO Kaizen Clinical Services to the BioClinica Certified Partner Program. Kaizen announcement

> Global CRO Rho joins Medidata's ASPire to Win channel partner program. Medidata announcement

> Mark Lanfear joins Advanced Clinical as VP for clinical operations. Advanced Clinical announcement

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.